Cardiosense is a rapidly growing, venture-backed medical AI company that is redefining how we detect, monitor, and manage heart disease. We're developing novel wearable sensors and advanced machine learning algorithms that translate raw physiological signals into clinically actionable, digital biomarkers used to detect early signs of cardiac worsening, guide personalized therapy, and improve patient outcomes. Our team brings together experts in data science, biosignal analysis, and medicine united by a common mission to identify and combat preventable cardiac disease. Cardiosense's solutions are built on over a decade of clinical research and we continue to collaborate with the world's leading academic institutions to introduce the next generation of cardiac monitoring and disease management.